Compare AUB & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUB | APGE |
|---|---|---|
| Founded | 1902 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.7B |
| IPO Year | N/A | 2023 |
| Metric | AUB | APGE |
|---|---|---|
| Price | $34.82 | $75.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $39.93 | ★ $99.57 |
| AVG Volume (30 Days) | ★ 1.0M | 767.4K |
| Earning Date | 01-22-2026 | 11-10-2025 |
| Dividend Yield | ★ 4.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $1,048,582,000.00 | N/A |
| Revenue This Year | $79.19 | N/A |
| Revenue Next Year | $14.11 | N/A |
| P/E Ratio | $19.62 | ★ N/A |
| Revenue Growth | ★ 41.48 | N/A |
| 52 Week Low | $22.85 | $26.20 |
| 52 Week High | $43.12 | $77.09 |
| Indicator | AUB | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 58.73 | 72.72 |
| Support Level | $33.94 | $70.54 |
| Resistance Level | $34.95 | $77.09 |
| Average True Range (ATR) | 0.88 | 3.54 |
| MACD | 0.23 | 0.32 |
| Stochastic Oscillator | 89.92 | 88.66 |
Atlantic Union Bankshares Corp is a financial holding company and a bank holding company. Through its community bank subsidiary, the company provides financial services, including banking, trust, and wealth management. The bank is a full-service community bank offering consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from Wholesale Banking.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.